Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Structural mechanism for statin inhibition of HMG-CoA reductase.
Multiple sclerosis: genetics, biomarkers, treatments.
MRI characteristics of familial and sporadic multiple sclerosis patients.
ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis.
A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register.
Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
Fingolimod for multiple sclerosis: a review for the specialist nurse.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
Minoderm
Pharmacodynamics, pharmacokinetics, and safety of multiple doses of FTY720 in stable renal transplant patients: a multicenter, randomized, placebo-controlled, phase I study.
Rationale and design of a clinical trial investigating resistance training as an aid to smoking cessation in persons with multiple sclerosis.
Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.
White matter volume is decreased in the brain of patients with neuromyelitis optica.
[Gluten-related disorders and demyelinating diseases.]
Protective effects of ginseng on neurological disorders.
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
The best basic science paper in multiple sclerosis in 2014: Important role for the choroid plexus in the central nervous system entry of leukocytes.
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Limb Apraxia in Multiple Sclerosis: Prevalence and Impact on Manual Dexterity and Activities of Daily Living.
Retinal Axonal Loss Begins Early in the Course of Multiple Sclerosis and Is Similar between Progressive Phenotypes.
[Lyme disease in patients with multiple sclerosis: clinical, diagnostic and therapeutic features.]
Breastfeeding is associated with lower risk for multiple sclerosis.
The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?
At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies
A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders

Pages